Glucotrack appoints diabetes expert Dr. Guillermo Umpierrez to Medical Advisory Board

Glucotrack, Inc.

Dr. Umpierrez, Professor of Medicine at Emory and past ADA president for Medicine & Science, joins effective immediately.
He will provide strategic guidance as Glucotrack advances its long-term implantable CBGM system through clinical development.
Glucotrack's CBGM has 3-year sensor life, no wearable component, and measures blood glucose directly to reduce lag time.
CEO Paul Goode cites Dr. Umpierrez's clinical and research expertise as valuable for upcoming human trials.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.